Disease progression in amyotrophic lateral sclerosis: Identifying the cost-utility of riluzole by disease stage

Manouchehr Tavakoli

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)156-165
JournalThe European Journal of Health Economics
Volume3
Issue number3
DOIs
Publication statusPublished - Sept 2002

Cite this